Clinical Trials Logo

Clinical Trial Summary

This open-label study aims to evaluate the safety and efficacy of autologous or allogeneic umbilical cord blood therapy for children with global developmental delay.


Clinical Trial Description

Global developmental delay is defined as significant delay in two or more of the following developmental domains: gross/fine motor, speech/language, cognition, social/personal, and activities of daily living.

Umbilical cord blood has been used for inherited metabolic diseases that feature global developmental delay and many experimental animal studies have revealed umbilical cord blood is useful to repair neurological impairments in brain. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01769716
Study type Interventional
Source Bundang CHA Hospital
Contact
Status Completed
Phase N/A
Start date December 2012
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT04511767 - Reliability and Validity of CCISO for Diagnosis of Autism Spectrum Disorder
Completed NCT01430845 - Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Completed NCT05408351 - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Completed NCT01601158 - Umbilical Cord Blood Therapy for Children With Global Developmental Delay N/A
Completed NCT03847402 - The Early Integrated Intervention for Child Brain-developmental Disorders in China N/A
Not yet recruiting NCT05418933 - Workshops for Children With Global Developmental Delays N/A
Completed NCT01441674 - Animal Assisted Therapy in a Pediatric Setting Phase 1/Phase 2
Recruiting NCT05879952 - Virtual Reality and Neuropsychiatric Rehabilitation in Patients With Global Developmental Delay. N/A
Completed NCT04816175 - Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay N/A
Completed NCT05398900 - Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children